Effects of Memantine to improve cognitive disorders caused by ECT in patients with major depressive disorder
Phase 2
- Conditions
- Major depressive disorder.Depressive episode
- Registration Number
- IRCT201506203930N38
- Lead Sponsor
- Shiraz University of Medical Sciences, Vice Chancellor for Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Aged between 18 to 65, both gender, major depressive dsorder using DSM-IV criteria
Exclusion criteria: serious medical condition, hypothyroidism, bipolar mood disorder, pregnancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression Score. Timepoint: Baseline, the last session of ECT and 2 weeks after the last session of ECT. Method of measurement: Minimal status Examination.
- Secondary Outcome Measures
Name Time Method